Skip to main content
  • Saved

from Pathologist Connect made a Post

Interesting findings... The clinical courses, including tumor stage at diagnosis, presence of brain metastasis, OS and RFS, are similar among lung adenocarcinoma patients with different KRAS mutation subtypes.

Concurrent PD-L1 expression and G12C mutation is associated with particularly poorer prognosis.